Delivery Order SPE2DB20D9354-SPE2DB25FX7Y8
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $8.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply to support Department of Defense healthcare requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (60-count units). The contract, which became effective on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 8, 2025, for 60 tablets of Xtandi 80 mg, an oncology medication. The delivery order is a firm fixed-price contract with a completion date of September 9, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL...
- The Defense Logistics Agency awarded a delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription medication commonly used in oncology treatment. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a direct supply of pharmaceutical products to support Department of Defense healthcare facilities. The award carries no set-aside designation, allowing DMS...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg on August 4, 2025. This firm fixed-price delivery order, issued under contract number 4568983056, represents a pharmaceutical supply requirement with a completion date of August 5, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xtandi 40 mg tablets (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription medication used in oncology treatment. The contract, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription oncology medication. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The order will be fulfilled and delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations as a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units) under contract number 4569035597. The award, valued at $4,169.59 with a firm fixed-price structure, was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and represents a continuation of...